Outcomes of ipsilateral simple limbal epithelial transplantation, tenonectomy, mitomycin and amniotic membrane transplantation for treatment of recurrent pterygium
Cornea Dec 04, 2020
Trinh T, Mimouni M, Mednick Z, et al. - In this retrospective, interventional study, researchers reported on the outcomes of recurrent pterygium treated by ipsilateral simple limbal epithelial transplantation (SLET), mitomycin, tenonectomy, and amniotic membrane transplantation. The sample consisted of all patients with recurrent pterygium who had SLET surgery under a single surgeon using ipsilateral donor tissue with a minimum 6-month follow-up at Toronto Western Hospital, Canada. Ten eyes of 10 patients, aged 60.7 ± 18.5 years (range 23–79) with a mean follow-up time of 15.2 ± 10.0 months of which 50% (n = 5) were men, were involved. Findings suggested that ipsilateral SLET with mitomycin, tenonectomy and amniotic membrane transplantation is a novel procedure for the treatment of recurrent pterygium. There are also concurrent limbal stem cell diseases. Initial results show low recurrence. Visual enhancement is modest. In order to improve vision, stabilization of the ocular surface is possible. There were no patients who needed a second operation.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries